We are live on ! Find out more
KALA icon

KALA BIO

21 hedge funds and large institutions have $4.81M invested in KALA BIO in 2023 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 7 increasing their positions, 5 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

40% more repeat investments, than reductions

Existing positions increased: 7 | Existing positions reduced: 5

0.13% less ownership

Funds ownership: 0.44%0.31% (-0.13%)

25% less funds holding

Funds holding: 2821 (-7)

63% less capital invested

Capital invested by funds: $12.8M → $4.81M (-$8.01M)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 7

100% less call options, than puts

Call options by funds: $0 | Put options by funds: $361K

Holders
21
Holders Change
-7
Holders Change %
-25%
% of All Funds
0.33%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
7
Reduced
5
Closed
7
Calls
Puts
$361K
Net Calls
-$361K
Net Calls Change
+$2.02M
Name Holding Trade Value Shares
Change
Change in
Stake
Renaissance Technologies
26
Renaissance Technologies
New York
-$404K -212 Closed
State Street
27
State Street
Massachusetts
-$381K -200 Closed
Geode Capital Management
28
Geode Capital Management
Massachusetts
-$340K -179 Closed
TSS
29
Two Sigma Securities
New York
-$249K -130 Closed
Royal Bank of Canada
30
Royal Bank of Canada
Ontario, Canada
-$11.3K -13 Closed
JP Morgan Chase
31
JP Morgan Chase
New York
-$8.72K -10 -91%
MA
32
MCF Advisors
Kentucky
-$8.77K -5 Closed

KALA Hedge Fund Activity: Q1 2023 in Review

21 of the 6,276 institutional investors tracked by Wall St. Rank reported a position in KALA BIO (KALA) for Q1 2023, worth a combined $4.81M — down 63% from $12.8M a quarter earlier.

Sellers outnumbered buyers: 7 funds closed out of KALA and 0 opened new positions — a net loss of 7 holders — while 5 trimmed existing stakes and 7 added.

The largest buyer was Millennium Management, adding an estimated $1.18M. The largest seller was Clear Street, exiting entirely with an estimated $1.88M sold.

  • 21 institutional investors held KALA BIO (KALA) as of Q1 2023, down from 28 in Q4 2022.
  • Funds reported $4.81M of KALA BIO stock for Q1 2023, down 63% quarter-over-quarter.
  • 0 funds opened new KALA BIO positions in Q1 2023 and 7 closed out, a net change of -7 holders.
  • The largest KALA BIO buyer in Q1 2023 was Millennium Management, an estimated $1.18M added.
  • The largest KALA BIO seller in Q1 2023 was Clear Street, an estimated $1.88M sold.

Based on aggregated 13F filings for Q1 2023.